![]() ![]() Echo showed EF recovery without the presence of a pericardial effusion. The patient had completed his steroid taper and laboratory markers and ECG were normal. ![]() At 6-week follow-up, the patient noted his pain was significantly improved. He was then given a 1-month prednisone taper (30 mg). Unfortunately, he discontinued aspirin therapy due to gastrointestinal distress. He was prescribed aspirin 650 mg TID and colchicine 0.6 mg BID. Given his clinical and imaging findings, he was diagnosed with perimyocarditis secondary to COVID-19 vaccination. Initial CMR with basal inferolateral and lateral myocardial involvement (arrows) and associated pericardial effusion (star).īNP: Brain Natriuretic Peptide CMR: Cardiac Magnetic Resonance Imaging DHE: Delayed Enhancement Hs-CRP: High Sensitivity C - reactive protein LV: Left Ventricle RV: Right Ventricle RV: Right Ventricle Outflow Tract Initial CMR with basal inferolateral and lateral myocardial involvement (arrows) and associated pericardial effusion (star).īNP: Brain Natriuretic Peptide CMR: Cardiac Magnetic Resonance Imaging DHE: Delayed Enhancement Hs-CRP: High Sensitivity C - reactive protein LV: Left Ventricle RV: Right Ventricle RV: Right Ventricle Outflow Tract A. In our patient, cardiac magnetic resonance imaging (CMR) identified a small pericardial effusion, and profound basal inferolateral and lateral myocardial involvement ( Figure 1A).Ī. Bedside echocardiography (echo) demonstrated mildly reduced ejection fraction (EF) (45%). Electrocardiogram (ECG) showed diffuse ST-segment elevation suggestive of pericarditis. Severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) IgG test was positive indicative of prior infection or prior vaccination status. Laboratory examination showed high sensitivity C-reactive protein (hs-CRP) (3.15 mg/L), high-sensitivity troponin T (126 ng/mL) and brain natriuretic peptide (105 pg/mL) levels were all elevated. He was taking no medications and had received his second dose of the Pfizer (BNT162b2) mRNA Coronavirus-19 disease (COVID-19) vaccine 3 days prior to symptoms onset. Cardiovascular exam showed regular rate, normal rhythm, S1, S2 sounds, and no pericardial rub. Physical examination and vital signs were within normal limits. The patient denied dyspnea, edema, and lightheadedness. He described his chest pain as squeezing with radiation to the back. A 22-year-old male with past medical history of Coxsackie myocarditis in 2019 presented to the emergency department with acute chest pressure and diaphoresis. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |